Join to View Full Profile
505 Parnassus AveRm M-987San Francisco, CA 94143
Phone+1 415-476-1528
Fax+1 415-502-1976
Dr. Scott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 2010 - 2012- University of California (San Francisco)Residency, Internal Medicine, 2006 - 2010
Yale School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2008 - 2025
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Personalized HIV and STI Testing Tool Start of enrollment: 2019 Sep 18
- HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing Start of enrollment: 2017 Jan 09
Publications & Presentations
PubMed
- 7 citationsDoxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and op...Anne F Luetkemeyer, Deborah Donnell, Stephanie E Cohen, Julia C Dombrowski, Cole Grabow
The Lancet. Infectious Diseases. 2025-08-01 - Implementation Barriers and Facilitators in a Pilot Long-Acting HIV Treatment Intervention for Trans Women Living with HIV in San Francisco.Erin C Wilson, Janet Myers, Geovanny Muñoz Acosta, Sofia Sicro, Emily Schaeffer
AIDS Patient Care and Stds. 2025-07-01 - Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in peop...Kelly E Seaton, Carmen A Paez, Chenchen Yu, Shelly T Karuna, Theresa Gamble
The Lancet. HIV. 2025-06-01
Press Mentions
Studies Show Longer-Term Benefits of doxyPEP for STI PreventionMarch 24th, 2025- Why Aren’t More People with HIV Accessing doxyPEP?March 18th, 2025
- CROI 2023: Dr. Dieffenbach Shares Research Highlights on Long-Acting HIV Prevention and Treatment, COVID, and a Cure UpdateFebruary 22nd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
